This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Hirotsu Bio Science Inc., Nanpuh Hospital. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Takuma Yoshinaga: Innovator in Cancer Detection
Introduction
Takuma Yoshinaga is a notable inventor based in Kagoshima, Japan. He has made significant contributions to the field of medical technology, particularly in cancer detection methods. His innovative approach utilizes tissue specimens to identify cancerous cells, showcasing his dedication to advancing healthcare solutions.
Latest Patents
Yoshinaga holds a patent for a cancer detection method using a tissue specimen. This method involves preparing a cell lysate from a region suspected to be cancerous and evaluating the behavior of a nematode in response to the cell lysate. This innovative technique offers a promising avenue for early cancer detection, potentially improving patient outcomes.
Career Highlights
Throughout his career, Takuma Yoshinaga has worked with prominent organizations such as Hirotsu Bio Science Inc. and Nanpuh Hospital. His experience in these institutions has allowed him to refine his research and contribute to significant advancements in cancer diagnostics.
Collaborations
Yoshinaga has collaborated with notable individuals in his field, including Takaaki Hirotsu and Hirotsu Takaaki. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Takuma Yoshinaga's work in cancer detection exemplifies the impact of innovative thinking in medical technology. His contributions are paving the way for more effective diagnostic methods, ultimately benefiting patients and the healthcare community.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile